Genome Editing Market Report 2024: CRISPR/Cas9 are the Most
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Viral Vector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The
A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.
A new study co-led by investigators from Mass Eye and Ear, a member of Mass General Brigham, demonstrated the effectiveness of a gene therapy towards restoring hearing function for children suffering from hereditary deafness.
Dr. Quentin Bazot, shares insights into his experience with the SamuxMP mass photometer for AAV process development